Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model

Area of Science:

• Infectious Diseases
• Parasitology
• Pharmacology

Background:

• Cryptosporidium parvum causes diarrhea in immunocompetent individuals.
• In immunocompromised hosts, particularly HIV-infected subjects, cryptosporidiosis leads to severe, chronic diarrhea.
• An effective treatment for cryptosporidiosis in vulnerable populations remains a critical unmet medical need.

Purpose of the Study:

• To compare the curative activity of nitazoxanide (NTZ), sinefungin (SNF), and paromomycin (PRM) against Cryptosporidium parvum.
• To evaluate the efficacy of these agents in a relevant animal model of immunosuppression.
• To assess the durability of treatment effects after drug discontinuation.

Main Methods:

• Immunosuppressed rats were used as a screening model for anticryptosporidial agents.
• Animals were treated with varying doses of NTZ (50, 100, 200 mg/kg/day), SNF (10 mg/kg/day), or PRM (100 mg/kg/day) for seven days.
• Oocyst shedding was monitored during and after treatment to assess efficacy and relapse rates.

Main Results:

• Nitazoxanide demonstrated a dose-dependent inhibition of oocyst shedding, comparable to SNF and PRM.
• Discontinuation of SNF or PRM therapy led to rapid relapse of oocyst shedding within 2-4 days.
• In contrast, NTZ treatment resulted in sustained inhibition of oocyst shedding seven days after therapy cessation.

Conclusions:

• Nitazoxanide exhibits potent and sustained anticryptosporidial activity in an immunosuppressed rat model.
• The sustained efficacy of NTZ post-treatment suggests a potential advantage over SNF and PRM for managing chronic or relapsing cryptosporidiosis.
• Further investigation into NTZ's activity against sequestered Cryptosporidium parvum is warranted.